ฝัง
- เผยแพร่เมื่อ 18 ก.ย. 2024
- AI-powered simulations could significantly cut down the 10 to 15-year time frame, and the up to $4 billion it typically takes to bring a new drug to the market. And SandboxAQ is doing it!
Finding the molecules that could be targets of new drugs is tedious, and the human body is so intricate that sometimes even good drug targets can lead to unforeseen off-target or side effects that are sometimes toxic. More than 80% of drug discovery programs fail, making it a slow and expensive process. But there's hope! SandboxAQ’s AQBioSim division is revolutionizing drug discovery with cutting-edge AI and quantum sensing technology.
Our innovative algorithms provide a more in-depth understanding of the molecular dynamics, and interactions between drugs and their targets, as well as the underlying biology of these interactions. Thus, boosting the chances of success in clinical trials, and minimizing the risk of toxicity. This means life-saving drugs can reach the market faster and more affordably. By starting with our advanced approach from day one, we shave years off the development process.
Our team works closely with clients to tackle real-world problems, offering speed, accuracy, and expert insights. SandboxAQ is leading the charge in AI and quantum-based drug discovery.
Want to learn more? Visit www.sandboxaq....
This is the kind of video in movie laboratories while the protagonist makes discoveries